{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:32:36Z","timestamp":1774121556880,"version":"3.50.1"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,19]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>While novel technologies such as high-throughput screening have advanced together with significant investment by pharmaceutical companies during the past decades, the success rate for drug development has not yet been improved prompting researchers looking for new strategies of drug discovery. Drug repositioning is a potential approach to solve this dilemma. However, experimental identification and validation of potential drug targets encoded by the human genome is both costly and time-consuming. Therefore, effective computational approaches have been proposed to facilitate drug repositioning, which have proved to be successful in drug discovery. Doubtlessly, the availability of open-accessible data from basic chemical biology research and the success of human genome sequencing are crucial to develop effective in silico drug repositioning methods allowing the identification of potential targets for existing drugs. In this work, we review several chemogenomic data-driven computational algorithms with source codes publicly accessible for predicting drug\u2013target interactions (DTIs). We organize these algorithms by model properties and model evolutionary relationships. We re-implemented five representative algorithms in R programming language, and compared these algorithms by means of mean percentile ranking, a new recall-based evaluation metric in the DTI prediction research field. We anticipate that this review will be objective and helpful to researchers who would like to further improve existing algorithms or need to choose appropriate algorithms to infer potential DTIs in the projects. The source codes for DTI predictions are available at: https:\/\/github.com\/minghao2016\/chemogenomicAlg4DTIpred.<\/jats:p>","DOI":"10.1093\/bib\/bby010","type":"journal-article","created":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T20:08:57Z","timestamp":1516997337000},"page":"1465-1474","source":"Crossref","is-referenced-by-count":31,"title":["Open-source chemogenomic data-driven algorithms for predicting drug\u2013target interactions"],"prefix":"10.1093","volume":"20","author":[{"given":"Ming","family":"Hao","sequence":"first","affiliation":[]},{"given":"Stephen H","family":"Bryant","sequence":"additional","affiliation":[]},{"given":"Yanli","family":"Wang","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"issue":"5","key":"2019100807490070000_bby010-B1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrd1384","article-title":"Prospects for productivity","volume":"3","author":"Booth","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"2019100807490070000_bby010-B2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"7\u20138","key":"2019100807490070000_bby010-B3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.drudis.2012.07.014","article-title":"Transcriptional data: a new gateway to drug repositioning?","volume":"18","author":"Iorio","year":"2013","journal-title":"Drug Discov Today"},{"issue":"7154","key":"2019100807490070000_bby010-B4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"issue":"8","key":"2019100807490070000_bby010-B5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2019100807490070000_bby010-B6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(08)70334-6","article-title":"Anti-HIV drugs for cancer therapeutics: back to the future?","volume":"10","author":"Chow","year":"2009","journal-title":"Lancet Oncol"},{"issue":"1","key":"2019100807490070000_bby010-B7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1758834011428147","article-title":"Sunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potential","volume":"4","author":"Delbaldo","year":"2012","journal-title":"Ther Adv Med Oncol"},{"key":"2019100807490070000_bby010-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(04)91001-9","article-title":"Imatinib as a paradigm of targeted therapies","volume":"91","author":"Druker","year":"2004","journal-title":"Adv Cancer Res"},{"issue":"4","key":"2019100807490070000_bby010-B9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nrc1323","article-title":"The evolution of thalidomide and its IMiD derivatives as anticancer agents","volume":"4","author":"Bartlett","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"26","key":"2019100807490070000_bby010-B10","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis","volume":"342","author":"Steinbach","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"2019100807490070000_bby010-B11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.trre.2005.01.001","article-title":"Rapamycin and tumor growth: mechanisms behind its anticancer activity","volume":"19","author":"Koehl","year":"2005","journal-title":"Transplant Rev"},{"issue":"1","key":"2019100807490070000_bby010-B12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2265.2007.02982.x","article-title":"Reduced thyroid volume and nodularity in dyslipidaemic patients on statin treatment","volume":"68","author":"Cappelli","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"10","key":"2019100807490070000_bby010-B13","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/CAD.0b013e32835739dd","article-title":"Valproic acid shows potent antitumor effect with alteration of DNA methylation in neuroblastoma","volume":"23","author":"Gu","year":"2012","journal-title":"Anti-Cancer Drugs"},{"issue":"3","key":"2019100807490070000_bby010-B14","doi-asserted-by":"crossref","first-page":"27.","DOI":"10.1186\/gm326","article-title":"Drug repositioning for personalized medicine","volume":"4","author":"Li","year":"2012","journal-title":"Genome Med"},{"issue":"10","key":"2019100807490070000_bby010-B15","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1021\/ci2002878","article-title":"Combined 3D-QSAR, molecular docking, and molecular dynamics study on piperazinyl-glutamate-pyridines\/pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation","volume":"51","author":"Hao","year":"2011","journal-title":"J Chem Inf Model"},{"issue":"12","key":"2019100807490070000_bby010-B16","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.3390\/ijms12118161","article-title":"In silico identification of structure requirement for novel thiazole and oxazole derivatives as potent fructose 1, 6-bisphosphatase inhibitors","volume":"12","author":"Hao","year":"2011","journal-title":"Int J Mol Sci"},{"key":"2019100807490070000_bby010-B17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jmgm.2011.12.010","article-title":"Exploring the structure requirement for PKC\u03b8 inhibitory activity of pyridinecarbonitrile derivatives: an in silico analysis","volume":"34","author":"Li","year":"2012","journal-title":"J Mol Graph Model"},{"issue":"6","key":"2019100807490070000_bby010-B18","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3109\/14756366.2011.554414","article-title":"Investigation on the binding mode of benzothiophene analogues as potent factor IXa (FIXa) inhibitors in thrombosis by CoMFA, docking and molecular dynamic studies","volume":"26","author":"Hao","year":"2011","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"4","key":"2019100807490070000_bby010-B19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10822-017-0009-6","article-title":"Predicting DPP-IV inhibitors with machine learning approaches","volume":"31","author":"Cai","year":"2017","journal-title":"J Comput Aided Mol Des"},{"issue":"10","key":"2019100807490070000_bby010-B20","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1021\/mp300237z","article-title":"Molecular fingerprint-based artificial neural networks QSAR for ligand biological activity predictions","volume":"9","author":"Myint","year":"2012","journal-title":"Mol Pharm"},{"issue":"9","key":"2019100807490070000_bby010-B21","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1021\/acs.jcim.5b00344","article-title":"Protein flexibility in docking-based virtual screening: discovery of novel lymphoid-specific tyrosine phosphatase inhibitors using multiple crystal structures","volume":"55","author":"Hou","year":"2015","journal-title":"J Chem Inf Model"},{"issue":"13","key":"2019100807490070000_bby010-B22","doi-asserted-by":"crossref","first-page":"i232","DOI":"10.1093\/bioinformatics\/btn162","article-title":"Prediction of drug-target interaction networks from the integration of chemical and genomic spaces","volume":"24","author":"Yamanishi","year":"2008","journal-title":"Bioinformatics"},{"issue":"11","key":"2019100807490070000_bby010-B23","doi-asserted-by":"crossref","first-page":"e80129.","DOI":"10.1371\/journal.pone.0080129","article-title":"Predicting drug-target interactions using drug-drug interactions","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"issue":"13","key":"2019100807490070000_bby010-B24","doi-asserted-by":"crossref","first-page":"i126","DOI":"10.1093\/bioinformatics\/btt234","article-title":"Predicting drug-target interactions using restricted Boltzmann machines","volume":"29","author":"Wang","year":"2013","journal-title":"Bioinformatics"},{"issue":"7","key":"2019100807490070000_bby010-B25","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3390\/molecules22071119","article-title":"Prediction of drug-target interaction networks from the integration of protein sequences and drug chemical structures","volume":"22","author":"Meng","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"2019100807490070000_bby010-B26","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1038\/s41598-017-10724-0","article-title":"In silico prediction of drug-target interaction networks based on drug chemical structure and protein sequences","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"2019100807490070000_bby010-B27","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/bib\/bbv066","article-title":"Drug-target interaction prediction: databases, web servers and computational models","volume":"17","author":"Chen","year":"2016","journal-title":"Brief Bioinform"},{"issue":"9","key":"2019100807490070000_bby010-B28","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1517\/17425255.2014.950222","article-title":"Drug-target interaction prediction via chemogenomic space: learning-based methods","volume":"10","author":"Mousavian","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"2019100807490070000_bby010-B29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/bib\/bbt056","article-title":"Similarity-based machine learning methods for predicting drug-target interactions: a brief review","volume":"15","author":"Ding","year":"2014","journal-title":"Brief Bioinform"},{"issue":"5","key":"2019100807490070000_bby010-B30","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1208\/s12248-017-0092-6","article-title":"Large-scale prediction of drug-target interaction: a data-centric review","volume":"19","author":"Cheng","year":"2017","journal-title":"AAPS J"},{"issue":"999","key":"2019100807490070000_bby010-B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1389210204916282037","article-title":"RFDT: a rotation forest-based predictor for predicting drug-target interactions using drug structure and protein sequence information","volume":"18","author":"Wang","year":"2016","journal-title":"Curr Protein Pept Sci"},{"key":"2019100807490070000_bby010-B32","first-page":"1","article-title":"A systematic prediction of drug-target interactions using molecular fingerprints and protein sequences","volume":"18","author":"Huang","year":"2017","journal-title":"Curr Protein Pept Sci"},{"issue":"2","key":"2019100807490070000_bby010-B33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry","volume":"25","author":"Keiser","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"9","key":"2019100807490070000_bby010-B34","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1021\/ci200192v","article-title":"Identifying compound-target associations by combining bioactivity profile similarity search and public databases mining","volume":"51","author":"Cheng","year":"2011","journal-title":"J Chem Inf Model"},{"issue":"18","key":"2019100807490070000_bby010-B35","doi-asserted-by":"crossref","first-page":"i522","DOI":"10.1093\/bioinformatics\/bts383","article-title":"Relating drug-protein interaction network with drug side effects","volume":"28","author":"Mizutani","year":"2012","journal-title":"Bioinformatics"},{"issue":"4","key":"2019100807490070000_bby010-B36","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1021\/ci400010x","article-title":"Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space","volume":"53","author":"Cheng","year":"2013","journal-title":"J Chem Inf Model"},{"issue":"5","key":"2019100807490070000_bby010-B37","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/1087057114522690","article-title":"Causal network models for predicting compound targets and driving pathways in cancer","volume":"19","author":"Jaeger","year":"2014","journal-title":"J Biomol Screen"},{"issue":"7","key":"2019100807490070000_bby010-B38","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1021\/ci200166t","article-title":"Enhancing the accuracy of chemogenomic models with a three-dimensional binding site kernel","volume":"51","author":"Meslamani","year":"2011","journal-title":"J Chem Inf Model"},{"issue":"7","key":"2019100807490070000_bby010-B39","doi-asserted-by":"crossref","first-page":"e1002574.","DOI":"10.1371\/journal.pcbi.1002574","article-title":"Assessing drug target association using semantic linked data","volume":"8","author":"Chen","year":"2012","journal-title":"PLoS Comput Biol"},{"issue":"7","key":"2019100807490070000_bby010-B40","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1039\/c2mb00002d","article-title":"Drug-target interaction prediction by random walk on the heterogeneous network","volume":"8","author":"Chen","year":"2012","journal-title":"Mol Biosyst"},{"key":"2019100807490070000_bby010-B41","doi-asserted-by":"crossref","first-page":"D354","DOI":"10.1093\/nar\/gkj102","article-title":"From genomics to chemical genomics: new developments in KEGG","volume":"34","author":"Kanehisa","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"39","key":"2019100807490070000_bby010-B42","doi-asserted-by":"crossref","first-page":"11853","DOI":"10.1021\/ja036030u","article-title":"Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in the metabolic pathways","volume":"125","author":"Hattori","year":"2003","journal-title":"J Am Chem Soc"},{"issue":"1","key":"2019100807490070000_bby010-B43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0022-2836(81)90087-5","article-title":"Identification of common molecular subsequences","volume":"147","author":"Smith","year":"1981","journal-title":"J Mol Biol"},{"issue":"90001","key":"2019100807490070000_bby010-B44","doi-asserted-by":"crossref","first-page":"431D","DOI":"10.1093\/nar\/gkh081","article-title":"BRENDA, the enzyme database: updates and major new developments","volume":"32","author":"Schomburg","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"2019100807490070000_bby010-B45","doi-asserted-by":"crossref","first-page":"D919","DOI":"10.1093\/nar\/gkm862","article-title":"SuperTarget and Matador: resources for exploring drug-target relationships","volume":"36","author":"G\u00fcnther","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"2019100807490070000_bby010-B46","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: a knowledgebase for drugs, drug actions and drug targets","volume":"36","author":"Wishart","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"2019100807490070000_bby010-B47","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/bioinformatics\/btp433","article-title":"Supervised prediction of drug-target interactions using bipartite local models","volume":"25","author":"Bleakley","year":"2009","journal-title":"Bioinformatics"},{"key":"2019100807490070000_bby010-B48","doi-asserted-by":"crossref","first-page":"40376.","DOI":"10.1038\/srep40376","article-title":"Predicting drug-target interactions by dual-network integrated logistic matrix factorization","volume":"7","author":"Hao","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"2019100807490070000_bby010-B49","doi-asserted-by":"crossref","first-page":"e1004760","DOI":"10.1371\/journal.pcbi.1004760","article-title":"Neighborhood regularized logistic matrix factorization for drug-target interaction prediction","volume":"12","author":"Liu","year":"2016","journal-title":"PLoS Comput Biol"},{"issue":"16","key":"2019100807490070000_bby010-B50","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/bioinformatics\/btt307","article-title":"Drug-target interaction prediction through domain-tuned network-based inference","volume":"29","author":"Alaimo","year":"2013","journal-title":"Bioinformatics"},{"key":"2019100807490070000_bby010-B51","article-title":"Logistic matrix factorization for implicit feedback data","volume":"27","author":"Johnson","year":"2014","journal-title":"Adv Neural Inf Process Syst"},{"key":"2019100807490070000_bby010-B52","author":"Hu","year":"2008"},{"key":"2019100807490070000_bby010-B53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.aca.2016.01.014","article-title":"Improved prediction of drug-target interactions using regularized least squares integrating with kernel fusion technique","volume":"909","author":"Hao","year":"2016","journal-title":"Anal Chim Acta"},{"issue":"3","key":"2019100807490070000_bby010-B54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nmeth.2810","article-title":"Similarity network fusion for aggregating data types on a genomic scale","volume":"11","author":"Wang","year":"2014","journal-title":"Nat Methods"},{"issue":"21","key":"2019100807490070000_bby010-B55","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1093\/bioinformatics\/btr500","article-title":"Gaussian interaction profile kernels for predicting drug-target interaction","volume":"27","author":"van Laarhoven","year":"2011","journal-title":"Bioinformatics"},{"issue":"1","key":"2019100807490070000_bby010-B56","doi-asserted-by":"crossref","first-page":"46.","DOI":"10.1186\/s12859-016-0890-3","article-title":"A multiple kernel learning algorithm for drug-target interaction prediction","volume":"17","author":"Nascimento","year":"2016","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"2019100807490070000_bby010-B57","doi-asserted-by":"crossref","first-page":"e66952.","DOI":"10.1371\/journal.pone.0066952","article-title":"Predicting drug-target interactions for new drug compounds using a weighted nearest neighbor profile","volume":"8","author":"van Laarhoven","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"2019100807490070000_bby010-B58","doi-asserted-by":"crossref","first-page":"128.","DOI":"10.1186\/s12859-016-0977-x","article-title":"A comparative study of SMILES-based compound similarity functions for drug-target interaction prediction","volume":"17","author":"\u00d6zt\u00fcrk","year":"2016","journal-title":"BMC Bioinformatics"},{"issue":"18","key":"2019100807490070000_bby010-B59","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/bioinformatics\/bts360","article-title":"Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization","volume":"28","author":"G\u00f6nen","year":"2012","journal-title":"Bioinformatics"},{"issue":"1","key":"2019100807490070000_bby010-B60","doi-asserted-by":"crossref","first-page":"388860","DOI":"10.1038\/srep38860","article-title":"Improved genome-scale multi-target virtual screening via a novel collaborative filtering approach to cold-start problem","volume":"6","author":"Lim","year":"2016","journal-title":"Sci Rep"},{"key":"2019100807490070000_bby010-B61","author":"Ma","year":"2009"},{"issue":"10","key":"2019100807490070000_bby010-B62","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1073\/pnas.1000488107","article-title":"Solving the apparent diversity-accuracy dilemma of recommender systems","volume":"107","author":"Zhou","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019100807490070000_bby010-B63","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ymeth.2015.04.036","article-title":"Predicting drug-target interaction for new drugs using enhanced similarity measures and super-target clustering","volume":"83","author":"Shi","year":"2015","journal-title":"Methods"},{"key":"2019100807490070000_bby010-B64","author":"R Core Team","year":"2017"},{"issue":"2","key":"2019100807490070000_bby010-B65","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/bib\/bbu010","article-title":"Toward more realistic drug-target interaction predictions","volume":"16","author":"Pahikkala","year":"2015","journal-title":"Brief Bioinform"},{"issue":"11","key":"2019100807490070000_bby010-B66","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nat Biotechnol"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/20\/4\/1465\/30119747\/bby010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/20\/4\/1465\/30119747\/bby010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T04:41:52Z","timestamp":1603687312000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/20\/4\/1465\/4840612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":66,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,2,6]]},"published-print":{"date-parts":[[2019,7,19]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bby010","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2018,2,6]]}}}